Cargando…

Prolactinomas : an interdisciplinary approach : Proceedings of the International Symposium on Prolactinomas Graz (Austria), April 29 - May 2, 1984 /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Auer, Ludwig M., Leb, Georg, Tscherne, Gerhard, Urdl, Wolfgang, Walter, Gerhard F.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Berlin ; Boston : De Gruyter, [2015]
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Frontmatter
  • Preface
  • Contents
  • I. Morphology
  • Structure and ultrastructure of prolactinomas
  • Prolactinomas and mixed adenomas with prolactin cells: an immunohistochemical study of the subcellular localization of hormones
  • Immunocytochemical, chemical and nuclear-DNA studies of pituitary tumours
  • Hyperplasia of prolactin pituitary cells with or with out microadenoma
  • Hormone-secretion in cell culture of microprolacti nomas, periadenomatous tissue and capsules
  • Immunocytochemical, ultrastructural and culture characteristics of prolactin-secreting pituitary adenomas
  • Immunohìstochemical hormone determinations in pituitary adenomas in comparison with endocrinological findings in vivo
  • New immunocytochemical observations in prolactinomas
  • Problematic divergencies between clinical and immunocytochemical findings in prolactinomas
  • Necrosis of prolactinoma cells after bromocriptine treatment
  • Spontaneous pituitary lesions and plasma prolactin levels in rats
  • II. Radiology
  • CT-findings in pituitary adenomas
  • Comparative study of normal subjects and cases with microadenoma on high-resolution computed tomography
  • III. Endocrinological and clinical aspects
  • Actions of dopamine receptor agonists at the pituitary level
  • Dopamine and prolactinomas
  • Rhythmometric study of the circadian profile of plasma prolactin in patients with prolactinoma or empty sella syndrome
  • Prolactin responses to thyrotropin-releasing hormone, metoclopramide and insulin-induced hypoglycaemia in hyperprolactinaemic and normoprolactinaemic patients
  • Evidence for functional impairment of growth hormone secretion in prolactinoma
  • TSH response to dopamine receptor blockade in women with PRL-secreting microadenoma: Long effect of surgical removal
  • Prolactin and TSH responses to TRH and domperidone in delayed puberty
  • Anterior pituitary function in patients with prolactinomas
  • Pituitary adenomas with hyperprolactinaemia in males
  • Prolactinoma in multiple endocrine neoplasia type I
  • Recurrence of hyperprolactinaemia detected in long-term follow-up of surgically normalized microprolactinomas
  • Impairment of pituitary hormone secretion in patients with prolactinoma
  • IV. Surgical treatment
  • The recurrence of pituitary adenoma
  • a management challenge
  • Transsphenoidal operations for prolactinomas
  • Prolactinomas: surgical results in 96 cases
  • Effect of transsphenoidal surgery on pituitary function
  • Transsphenoidal microsurgical treatment of 77 prolactinomas
  • Review of 56 prolactin-secreting pituitary adenomas
  • The effect of transsphenoidal selective microadenomectomy on patients with prolactinomas
  • Surgical results and long-term follow-up in female and male prolactinomas
  • Otoliquorrhoea in large prolactinomas. Pathomechanism and surgical management
  • Invasive prolactinomas in adolescents
  • Residual anterior pituitary function following transsphenoidal resection of pituitary macroadenomas
  • Long-term follow-up of prolactinomas. Clinical and morphologic correlation
  • Clinicopathologîcal and neurosurgical comparative analysis of operated recurrent prolactinomas and non-secreting chromophobe pituitary adenomas
  • V. Pharmacotherapy
  • New aspects of medical treatment of prolactinomas
  • Conservative management of prolactinoma
  • Effect of bromocriptine therapy on large prolactinomas
  • Macroprolactinomas in male patients: efficiency of treatment with a new dopaminergic drug (CU 32-085-Sandoz), tumour calcification and relative significance of preoperative tumour volume regression as estimated by CT-scan
  • Evidence for spontaneous tumour shrinkage in a 45-year-old patient with a 20-year history of untreated microprolactinoma
  • The influence of various forms of treatment on serum levels of prolactin, growth hormone and insulin-like growth factors I and II in patients with hyperprolactinaemia and acromegaly
  • Persisting partial suppression of growth hormone excess in acromegaly after long term treatment with bromocriptine
  • Medical and surgical treatment of micro and macroprolactinomas: seven years follow-up of 65 cases
  • VI. Aspects of gynecology and obstetrics
  • Management of prolactinomas in pregnancy
  • Long-term follow-up of hyperprolactinaemia in women
  • Prophylactic bromocriptine treatment during pregnancy of women with macroprolactinomas: report of thirteen pregnancies
  • Natural regression after pregnancy of a CT visualized microprolactinoma
  • Prolactin levels and ovarian function after surgical treatment of prolactinomas
  • Pregnancies after treatment of prolactinomas: course and complications
  • Psychosomatic findings in patients with elevated prolactin
  • List of contributors
  • Authors' index
  • Subject index.